P3 Health Partners (NASDAQ:PIII) Earns Buy Rating from Analysts at Lake Street Capital

Key Points

• Lake Street Capital has reiterated a "buy" rating for P3 Health Partners (PIII), with a price target of $20.00, indicating a potential upside of 154.78% from the current price.
• P3 Health Partners reported a quarterly loss of ($6.23) EPS, falling short of analyst expectations, and had a revenue of $355.79 million for the quarter.
• Institutional investors have shown increasing interest in P3 Health Partners, with significant stake acquisitions, including a 77.3% increase by Abundance Wealth Counselors in the first quarter.

Investment analysts at Lake Street Capital initiated coverage on shares of P3 Health Partners (NASDAQ:PIII - Get Free Report) in a report issued on Thursday, MarketBeat reports. The firm set a "buy" rating and a $20.00 price target on the stock. Lake Street Capital's price objective points to a potential upside of 154.78% from the stock's current price.

P3 Health Partners Stock Performance

Shares of NASDAQ PIII opened at $7.85 on Thursday. The stock has a market cap of $56.44 million, a price-to-earnings ratio of -0.17 and a beta of 0.81. The company has a current ratio of 0.31, a quick ratio of 0.31 and a debt-to-equity ratio of 2.29. P3 Health Partners has a 1-year low of $5.80 and a 1-year high of $29.19. The stock's 50-day moving average is $6.75 and its 200 day moving average is $7.97.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($6.23) earnings per share for the quarter, missing analysts' consensus estimates of ($3.29) by ($2.94). The firm had revenue of $355.79 million for the quarter, compared to analysts' expectations of $356.52 million. P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. P3 Health Partners has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that P3 Health Partners will post -0.67 EPS for the current fiscal year.

Institutional Investors Weigh In On P3 Health Partners

Large investors have recently made changes to their positions in the business. Cresset Asset Management LLC grew its position in shares of P3 Health Partners by 33.3% in the 1st quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock worth $33,000 after buying an additional 50,000 shares during the last quarter. XTX Topco Ltd bought a new stake in shares of P3 Health Partners in the 4th quarter worth approximately $46,000. Wealthedge Investment Advisors LLC bought a new stake in shares of P3 Health Partners during the fourth quarter valued at approximately $83,000. Abundance Wealth Counselors boosted its position in shares of P3 Health Partners by 77.3% during the first quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock valued at $66,000 after purchasing an additional 174,395 shares in the last quarter. Finally, Trinity Financial Advisors LLC boosted its position in shares of P3 Health Partners by 22.5% during the first quarter. Trinity Financial Advisors LLC now owns 1,278,037 shares of the company's stock valued at $222,000 after purchasing an additional 234,500 shares in the last quarter. 7.75% of the stock is currently owned by institutional investors.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.